Allocator Intelligence
The capital-owner graph behind private markets. Who owns the capital, who decides, how much, under what policy, on whose advice, to which managers, and what changed, with a source and a date behind every row. A target is never an actual, a disclosed holding is never an approval, and an estimate says so.
The Cullen Foundation of Western New York Inc: what the board decided
Read from the boards’ own minutes and meeting packets, each row with the stance the minutes give it. Approved is a vote or a commitment reported as made under delegated authority; recommended is staff or the consultant asking, with no vote in the record; proposed is an item presented for consideration. Every row carries the sentence that says so. A re-up prospect is arithmetic on the tape: the allocator holds Fund N, the manager has Fund N+1 open, and no commitment to it is on the graph; it is labelled an inference and says nothing about intent.
Same manager, same series and name stem, the next number (or a later vintage), open now on the venture or private equity graph, and no commitment to it on this graph. Dated at the successor’s first Form D sale when there is one. A row retires by itself when a commitment to the successor lands.
- Sep 16, 2026Re-up prospectreport dateinferenceThe Cullen Foundation of Western New York Inc holds SPARK CAPITAL GROWTH FUND IV, LP; the manager is raising: Spark Capital Growth Fund VI, L.P. (fundraising, seen 2026-09-16); no commitment to it on the graph; 1 fund(s) of the series between them not held eitherwith Spark Capitalno URL
- Sep 16, 2026Re-up prospectreport dateinferenceThe Cullen Foundation of Western New York Inc holds SPARK CAPITAL VIII, LP; the manager is raising: Spark Capital IX, L.P. (fundraising, seen 2026-09-16); no commitment to it on the graphwith Spark Capitalno URL
- Jun 28, 2024Re-up prospectinferenceThe Cullen Foundation of Western New York Inc holds VENBIO GLOBAL STRATEGIC FUND IV, L.P.; the manager has a newer fund open: venBio Global Strategic Fund V, L.P. (early deployment, Form D first sale 2024-06-28); no commitment to it on the graphwith Venbio Partners LLCno URL